Targeting TP53TG1: a promising prognostic biomarker and therapeutic target for personalized cancer therapy
Abstract Tumor protein p53 target gene 1 (TP53TG1) is a significant long non-coding RNA (lncRNA) located on human chromosome 7q21.12, exhibiting dysregulated expression in several cancer tissues, and operates both as an oncogene and a tumor suppressor. TP53TG1 modulates gene expression by several me...
Saved in:
| Main Author: | Haodong He |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2025-07-01
|
| Series: | Discover Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s12672-025-03065-2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Identification and prognostic analysis of metabolic genes associated with TP53 mutation in multiple myeloma
by: Xiaoyan Tang, et al.
Published: (2024-12-01) -
TERT-TP53 mutations: a novel biomarker pair for hepatocellular carcinoma recurrence and prognosis
by: Jin Li, et al.
Published: (2025-01-01) -
In-frame germline TP53 variant impairs p53 oligomerization and predisposes to cancer
by: Lucie Vanikova, et al.
Published: (2025-08-01) -
Impact of TP53 mutations on the efficacy of CAR-T cell therapy in cancer
by: Regina Mirgayazova, et al.
Published: (2024-12-01) -
Plasma ctDNA TP53 Mutation and Breast Cancer Prognosis: A Systematic Review and Meta-Analysis
by: FAN Hao, et al.
Published: (2025-07-01)